{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:49:54Z","timestamp":1791568194267,"version":"4.3.4"},"reference-count":301,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.addr.2026.115975","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:40:42Z","timestamp":1790869242000},"page":"115975","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Poly(2-oxazoline)s and poly(2-oxazine)s: An overview of stealth properties, pharmacokinetics, and immunogenicity"],"prefix":"10.1016","volume":"239","author":[{"given":"Somdeb","family":"Jana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Hoogenboom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115975_bb0005","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.3390\/ijms26073102","article-title":"The art of PEGylation: from simple polymer to sophisticated drug delivery system","volume":"26","author":"Makharadze","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jconrel.2014.12.008","article-title":"Polyethylene glycol (PEG)-dendron phospholipids as innovative constructs for the preparation of super stealth liposomes for anticancer therapy","volume":"199","author":"Pasut","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/00003088-200342050-00002","article-title":"Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies","volume":"42","author":"Gabizon","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.addr.2026.115975_bb0025","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0169-409X(03)00108-X","article-title":"Pharmacokinetic and biodistribution properties of poly (ethylene glycol)\u2013protein conjugates","volume":"55","author":"Caliceti","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0030","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12079-018-0492-0","article-title":"Protein PEGylation for cancer therapy: bench to bedside","volume":"13","author":"Gupta","year":"2019","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.addr.2026.115975_bb0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0169-409X(95)00023-Z","article-title":"Chemistry of polyethylene glycol conjugates with biologically active molecules","volume":"16","author":"Zalipsky","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0040","article-title":"Immunogenicity of polyethylene glycol based nanomedicines: mechanisms, clinical implications and systematic approach","volume":"3","author":"d'Avanzo","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.addr.2026.115975_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jconrel.2011.10.037","article-title":"State of the art in PEGylation: the great versatility achieved after forty years of research","volume":"161","author":"Pasut","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0055","doi-asserted-by":"crossref","first-page":"6288","DOI":"10.1002\/anie.200902672","article-title":"Poly (ethylene glycol) in drug delivery: pros and cons as well as potential alternatives","volume":"49","author":"Knop","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0060","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10600","article-title":"PEGylated therapeutics in the clinic","volume":"9","author":"Gao","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.addr.2026.115975_bb0065","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1056\/NEJMra2035343","article-title":"Maintaining safety with SARS-CoV-2 vaccines","volume":"384","author":"Castells","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115975_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-023-00766-z","article-title":"Polyethylene glycol (PEG)-associated immune responses triggered by clinically relevant lipid nanoparticles in rats","volume":"8","author":"Wang","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.addr.2026.115975_bb0080","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4500","article-title":"Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients","volume":"16","author":"Hershfield","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2026.115975_bb0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jnt5030007","article-title":"Anti-poly(ethylene glycol)(PEG) antibodies: from where are we coming and where are we going","volume":"5","author":"Simberg","year":"2024","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.addr.2026.115975_bb0090","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil\u00ae): possible role in hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.addr.2026.115975_bb0095","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.molimm.2008.08.276","article-title":"Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process","volume":"46","author":"Hamad","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.addr.2026.115975_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jconrel.2021.11.042","article-title":"Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement","volume":"341","author":"Senti","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0105","first-page":"36","article-title":"Polyethylene glycol reactive antibodies in man: titer distribution in allergic patients treated with monomethoxy polyethylene glycol modified allergens or placebo, and in healthy blood donors","volume":"74","author":"Richter","year":"1984","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.addr.2026.115975_bb0110","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0115","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb0120","doi-asserted-by":"crossref","first-page":"22594","DOI":"10.1039\/D5NR02301G","article-title":"The curious case of anti-PEG antibodies","volume":"17","author":"Denman","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2026.115975_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17081074","article-title":"Anti-PEG antibodies and their biological impact on PEGylated drugs: challenges and strategies for optimization","volume":"17","author":"Fu","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115975_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123695","article-title":"Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines","volume":"650","author":"Yang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb0135","doi-asserted-by":"crossref","DOI":"10.1186\/ar4497","article-title":"Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout","volume":"16","author":"Lipsky","year":"2014","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2026.115975_bb0140","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.jaci.2015.10.034","article-title":"Pre-existing anti\u2013polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer","volume":"137","author":"Ganson","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2026.115975_bb0145","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/j.jaci.2016.04.058","article-title":"Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer","volume":"138","author":"Povsic","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.addr.2026.115975_bb0150","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s44222-025-00321-6","article-title":"Polyethylene glycol immunogenicity in nanomedicine","volume":"3","author":"Chen","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.addr.2026.115975_bb0155","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115925","article-title":"Anti-PEG antibodies in nanomedicine: mechanisms, risks, and opportunities","volume":"236","author":"Mihindukulasooriya","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jconrel.2018.06.002","article-title":"A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse","volume":"284","author":"McSweeney","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2006.08.017","article-title":"Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection","volume":"115","author":"Ishida","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0175","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1021\/acs.molpharmaceut.5b00144","article-title":"Anti-PEG IgM is a major contributor to the accelerated blood clearance of polyethylene glycol-conjugated protein","volume":"12","author":"Mima","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb0180","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jcph.1824","article-title":"PEG that reaction: a case series of allergy to polyethylene glycol","volume":"61","author":"Cox","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.addr.2026.115975_bb0185","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.1021\/acsnano.2c12193","article-title":"Antibodies against poly(ethylene glycol) activate innate immune cells and induce hypersensitivity reactions to PEGylated nanomedicines","volume":"17","author":"Chen","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26873","article-title":"Outcome of pediatric patients with acute lymphoblastic leukemia\/lymphoblastic lymphoma with hypersensitivity to pegaspargase treated with PEGylated Erwinia asparaginase, pegcrisantaspase: a report from the children\u2019s oncology group","volume":"65","author":"Rau","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.addr.2026.115975_bb0195","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. Coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.addr.2026.115975_bb0200","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1016\/j.jaip.2022.07.012","article-title":"Reporting of allergic reactions during Pfizer-BioNTech BNTT162B2 vaccination in Israel","volume":"10","author":"Anis","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.addr.2026.115975_bb0205","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2023.01.012","article-title":"Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice","volume":"354","author":"Ibrahim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0215","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0220","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxrep.2020.12.022","article-title":"Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma","volume":"8","author":"Fang","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.addr.2026.115975_bb0225","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2022.12.039","article-title":"Anti-PEG antibodies before and after a first dose of Comirnaty\u00ae(mRNA-LNP-based SARS-CoV-2 vaccine)","volume":"354","author":"Bavli","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0230","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/cea.13874","article-title":"Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer\/BioNTech mRNA COVID-19 vaccine","volume":"51","author":"Sellaturay","year":"2021","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.addr.2026.115975_bb0235","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/j.bja.2020.12.020","article-title":"Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?","volume":"126","author":"Garvey","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.addr.2026.115975_bb0240","doi-asserted-by":"crossref","first-page":"e2125524","DOI":"10.1001\/jamanetworkopen.2021.25524","article-title":"Assessment of allergic and anaphylactic reactions to mRNA COVID-19 vaccines with confirmatory testing in a US regional health system","volume":"4","author":"Warren","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.addr.2026.115975_bb0245","first-page":"e2021519","article-title":"Hypersensitivity to polyethylene glycol in adults and children: an emerging challenge","volume":"92","author":"Bianchi","year":"2021","journal-title":"Acta Biomed."},{"key":"10.1016\/j.addr.2026.115975_bb0250","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/j.jaip.2021.06.010","article-title":"First-dose mRNA COVID-19 vaccine allergic reactions: limited role for excipient skin testing","volume":"9","author":"Wolfson","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.addr.2026.115975_bb0255","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3390\/nu13082637","article-title":"COVID-19 vaccines in children with cow\u2019s milk and food allergies","volume":"13","author":"Liotti","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.addr.2026.115975_bb0260","doi-asserted-by":"crossref","first-page":"4561","DOI":"10.1016\/j.vaccine.2023.06.009","article-title":"Role of anti-polyethylene glycol (PEG) antibodies in the allergic reactions to PEG-containing Covid-19 vaccines: evidence for immunogenicity of PEG","volume":"41","author":"Kozma","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2026.115975_bb0265","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/all.14711","article-title":"Allergic reactions to the first COVID-19 vaccine: a potential role of polyethylene glycol?","volume":"76","author":"Cabanillas","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.addr.2026.115975_bb0270","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2024.01.003","article-title":"Development of anti-PEG IgG\/IgM\/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy","volume":"366","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics18101196","article-title":"Evaluating the role of anti-PEG antibodies in hypersensitivity to PEG-Asparaginase through clinically relevant cut-points defined by ELISA and Surface Plasmon resonance","volume":"18","author":"Rossi","year":"2026","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115975_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2005.06.001","article-title":"Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products","volume":"214","author":"Fruijtier-Polloth","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.addr.2026.115975_bb0285","doi-asserted-by":"crossref","first-page":"14980","DOI":"10.1038\/s41598-024-65504-4","article-title":"ToF-SIMS evaluation of PEG-related mass peaks and applications in PEG detection in cosmetic products","volume":"14","author":"Shen","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115975_bb0290","article-title":"Refined exposure assessment of polyethylene glycol (E 1521) from its use as a food additive","volume":"16","author":"Younes","year":"2018","journal-title":"EFSA J."},{"key":"10.1016\/j.addr.2026.115975_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2015.06.023","article-title":"The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes","volume":"213","author":"Kierstead","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0300","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2023.07.031","article-title":"Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery","volume":"361","author":"Berger","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0305","doi-asserted-by":"crossref","DOI":"10.1002\/mabi.201700061","article-title":"Peptosomes for vaccination: combining antigen and adjuvant in polypept(o)ide-based polymersomes","volume":"17","author":"Weber","year":"2017","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2026.115975_bb0310","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1021\/acsanm.0c01834","article-title":"Polysarcosine-functionalized lipid nanoparticles for therapeutic mRNA delivery","volume":"3","author":"Nogueira","year":"2020","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.addr.2026.115975_bb0315","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/js9504043","article-title":"Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes","volume":"85","author":"Zalipsky","year":"1996","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2016.05.048","article-title":"\u03bcPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)","volume":"235","author":"Wyffels","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fddev.2024.1383038","article-title":"Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation","volume":"4","author":"Van Zyl","year":"2024","journal-title":"Front. Drug Deliv."},{"key":"10.1016\/j.addr.2026.115975_bb0330","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.addr.2009.11.029","article-title":"Micelles based on HPMA copolymers","volume":"62","author":"Talelli","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0335","article-title":"Polymeric nanoparticles with neglectable protein corona","volume":"16","author":"Alberg","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.addr.2026.115975_bb0340","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpharm.2013.07.059","article-title":"Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration","volume":"456","author":"Lila","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb0345","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.biomac.8b00115","article-title":"Comparison of linear and hyperbranched polyether lipids for liposome shielding by 18F-radiolabeling and positron emission tomography","volume":"19","author":"Wagener","year":"2018","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0350","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1021\/acs.biomac.0c01627","article-title":"Polyglycerol for half-life extension of proteins\u2014alternative to PEGylation?","volume":"22","author":"Tully","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119521","article-title":"Blood retention and antigenicity of polycarboxybetaine-modified liposomes","volume":"586","author":"Ryujin","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb0360","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.1021\/la200227b","article-title":"Zwitteration as an alternative to PEGylation","volume":"27","author":"Estephan","year":"2011","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115975_bb0365","doi-asserted-by":"crossref","first-page":"13873","DOI":"10.1002\/anie.201808615","article-title":"Revealing the immunogenic risk of polymers","volume":"57","author":"Li","year":"2018","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2026.115975_bb0370","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1039\/C7BM00747G","article-title":"Zwitterionic stealth peptide-protected gold nanoparticles enable long circulation without the accelerated blood clearance phenomenon","volume":"6","author":"Zhao","year":"2018","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0375","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202000406","article-title":"Sulfoxide-containing polymer-coated nanoparticles demonstrate minimal protein fouling and improved blood circulation","volume":"7","author":"Qiao","year":"2020","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0380","article-title":"Poly(N-methyl-N-vinylacetamide): a strong alternative to PEG for lipid-based nanocarriers delivering siRNA","volume":"13","author":"Berger","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb0385","doi-asserted-by":"crossref","DOI":"10.1002\/advs.77145","article-title":"Beyond PEG: emerging polymer lipid alternatives for lipid nanoparticle (LNP) formulations","volume":"13","author":"Mazrad","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0390","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.progpolymsci.2018.07.005","article-title":"Pharmapolymers in the 21st century: synthetic polymers in drug delivery applications","volume":"87","author":"Englert","year":"2018","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101738","article-title":"Poly(ethylene glycol) alternatives in biomedical applications","volume":"48","author":"Yao","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2026.115975_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.879988","article-title":"PEG: will it come back to you? Polyethelyne glycol immunogenicity, COVID vaccines, and the case for new PEG derivatives and alternatives","volume":"10","author":"Kong","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2026.115975_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/polym12020298","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2026.115975_bb0410","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1039\/c0py00406e","article-title":"Overcoming the PEG-addiction: well-defined alternatives to PEG, from structure\u2013property relationships to better defined therapeutics","volume":"2","author":"Barz","year":"2011","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/molecules31040675","article-title":"From PEGylation to next-generation polymers: overcoming biological barriers\u2013a review","volume":"31","author":"Iminova","year":"2026","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2026.115975_bb0420","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.biomaterials.2018.05.022","article-title":"Poly(2-oxazoline)s based biomaterials: a comprehensive and critical update","volume":"178","author":"Lorson","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0425","doi-asserted-by":"crossref","first-page":"114838","DOI":"10.1016\/j.jconrel.2026.114838","article-title":"Poly(2-oxazoline) and poly(2-oxazine)-based nanomedicines: advancements, opportunities and challenges","volume":"394","author":"Humphries","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0430","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.201900168","article-title":"Drug delivery systems based on poly(2-oxazoline)s and poly(2-oxazine)s","volume":"3","author":"Sedlacek","year":"2020","journal-title":"Adv. Therap."},{"key":"10.1016\/j.addr.2026.115975_bb0435","doi-asserted-by":"crossref","first-page":"7978","DOI":"10.1002\/anie.200901607","article-title":"Poly(2-oxazoline)s: a polymer class with numerous potential applications","volume":"48","author":"Hoogenboom","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0440","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/marc.201200453","article-title":"Poly (2-Oxazoline)s\u2013are they more advantageous for biomedical applications than other polymers?","volume":"33","author":"Sedlacek","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0445","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.addr.2007.08.018","article-title":"Poly(2-oxazolines) in biological and biomedical application contexts","volume":"59","author":"Adams","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001382","article-title":"Poly(2-oxazoline)-and poly(2-oxazine)-based self-assemblies, polyplexes, and drug nanoformulations\u2014an update","volume":"10","author":"Zahoranova","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb0455","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jconrel.2007.10.010","article-title":"Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?","volume":"125","author":"Mero","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0460","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s13233-023-00116-x","article-title":"Poly(2-oxazoline)s: synthesis and biomedical applications","volume":"31","author":"Yang","year":"2023","journal-title":"Macromol. Res."},{"key":"10.1016\/j.addr.2026.115975_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114292","article-title":"Poly(2-oxazoline)-based drug delivery systems for cancer therapy","volume":"239","author":"Kulkarni","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0470","first-page":"2253","article-title":"Homopolymerization of 2-alkyl- and 2-aryl-2-oxazolines","volume":"4","author":"Tomalia","year":"1966","journal-title":"Journal of Polymer Science Part A-1: Polymer Chemistry"},{"key":"10.1016\/j.addr.2026.115975_bb0475","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/anie.196608751","article-title":"Recent syntheses and reactions of cyclic Imidic esters","volume":"5","author":"Seeliger","year":"1966","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0480","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/pol.1967.110050927","article-title":"Polymerization of cyclic imino ethers. I. Oxazolines","volume":"5","author":"Bassiri","year":"1967","journal-title":"Journal of Polymer Science Part B: Polymer Letters"},{"key":"10.1016\/j.addr.2026.115975_bb0485","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/pol.1966.110040701","article-title":"Ring-opening polymerization of 2-substituted 2-oxazolines","volume":"4","author":"Kagiya","year":"1966","journal-title":"Journal of Polymer Science Part B: Polymer Letters"},{"key":"10.1016\/j.addr.2026.115975_bb0490","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1002\/anie.201807796","article-title":"Defined high molar mass poly(2-oxazoline)s","volume":"57","author":"Monnery","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0495","series-title":"Practical Applications in Biomedical Engineering","first-page":"257","article-title":"Biocompatibility and Immunocompatibility assessment of poly(2-Oxazolines)","author":"Kronek","year":"2013"},{"key":"10.1016\/j.addr.2026.115975_bb0500","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2011.04.010","article-title":"Structure-property relationship in cytotoxicity and cell uptake of poly(2-oxazoline) amphiphiles","volume":"153","author":"Luxenhofer","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0505","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biomaterials.2015.04.059","article-title":"Biocompatibility of poly(2-alkyl-2-oxazoline) brush surfaces for adherent lung cell lines","volume":"61","author":"Tait","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0510","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1039\/C8NR00835C","article-title":"Human plasma proteome association and cytotoxicity of nano-graphene oxide grafted with stealth polyethylene glycol and poly(2-ethyl-2-oxazoline)","volume":"10","author":"Wang","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.addr.2026.115975_bb0515","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/mabi.201200017","article-title":"Poly(2-ethyl-2-oxazoline) as alternative for the stealth polymer poly(ethylene glycol): comparison of in vitro cytotoxicity and Hemocompatibility","volume":"12","author":"Bauer","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2026.115975_bb0520","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/marc.201200422","article-title":"Polyoxazolines for nonfouling surface coatings\u2014a direct comparison to the gold standard PEG","volume":"33","author":"Konradi","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0525","doi-asserted-by":"crossref","first-page":"7998","DOI":"10.1039\/c3cs60161g","article-title":"Poly (2-oxazoline) functionalized surfaces: from modification to application","volume":"42","author":"Tauhardt","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0530","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1021\/acs.biomac.4c00726","article-title":"Poly(2-oxazoline)-based Thermoresponsive Stomatocytes","volume":"25","author":"Terracciano","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0535","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.1021\/acs.macromol.5c00771","article-title":"Thermoresponsive poly(2-Oxazoline)s with pH-degradable Acetal side chains as potential drug delivery vehicles","volume":"58","author":"Jana","year":"2025","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0540","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1039\/C6PY01320A","article-title":"Thermoresponsive poly(2-oxazoline)s, polypeptoids, and polypeptides","volume":"8","author":"Hoogenboom","year":"2017","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0545","doi-asserted-by":"crossref","DOI":"10.1016\/j.progpolymsci.2020.101252","article-title":"Poly(2-oxazoline)-based stimulus-responsive (co)polymers: an overview of their design, solution properties, surface-chemistries and applications","volume":"106","author":"Jana","year":"2020","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0550","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3390\/polym5030956","article-title":"Design strategies for functionalized poly(2-oxazoline)s and derived materials","volume":"5","author":"Rossegger","year":"2013","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2026.115975_bb0555","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eurpolymj.2015.01.014","article-title":"Poly(2-oxazoline)s and click chemistry: a versatile toolbox toward multi-functional polymers","volume":"65","author":"Lava","year":"2015","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0560","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1021\/acs.macromol.4c02523","article-title":"Unraveling Structure\u2013Reactivity and Structure\u2013Property Relationships for the Amidation of Methyl Ester-Functionalized Poly(2-Oxazoline)s","volume":"58","author":"Podevyn","year":"2025","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0565","doi-asserted-by":"crossref","first-page":"12498","DOI":"10.1021\/jacs.9b06009","article-title":"Living polymerization of 2-Ethylthio-2-oxazoline and Postpolymerization diversification","volume":"141","author":"Wu","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb0570","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1021\/acs.biomac.8b01366","article-title":"Straightforward route to Superhydrophilic poly(2-oxazoline)s via acylation of well-defined Polyethylenimine","volume":"20","author":"Sedlacek","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0575","article-title":"Short guanidinium-functionalized poly(2-oxazoline)s displaying potent therapeutic efficacy on drug-resistant fungal infections","volume":"61","author":"Jiang","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0580","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/15583724.2018.1496930","article-title":"Poly(2-oxazoline)-containing triblock copolymers: synthesis and applications","volume":"59","author":"Sahn","year":"2019","journal-title":"Polym. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb0585","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eurpolymj.2016.10.034","article-title":"Amphiphilic poly(2-oxazoline) copolymers as self-assembled carriers for drug delivery applications","volume":"88","author":"Vlassi","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0590","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.1021\/ma0007381","article-title":"Functionalization of amphiphilic poly(2-oxazoline) block copolymers: a novel class of macroligands for micellar catalysis","volume":"33","author":"Persigehl","year":"2000","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0595","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s10856-012-4621-7","article-title":"Immunomodulatory efficiency of poly(2-oxazolines)","volume":"23","author":"Kronek","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.addr.2026.115975_bb0600","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1039\/C5CC00260E","article-title":"Plasma polymerised polyoxazoline thin films for biomedical applications","volume":"51","author":"Ramiasa","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0605","article-title":"Tailoring cationic poly(2-oxazoline)s: minimizing toxicity and immunogenic response for biological applications","volume":"44","author":"Streiber","year":"2025","journal-title":"Mater. Today Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0610","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jss.2024.03.033","article-title":"Clinical safety and performance of GATT-patch for hemostasis in minimal to moderate bleeding during open liver surgery","volume":"298","author":"de Wilt","year":"2024","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.addr.2026.115975_bb0615","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/acs.biomac.7b00683","article-title":"Next generation hemostatic materials based on NHS-ester functionalized poly(2-oxazoline)s","volume":"18","author":"Boerman","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0620","series-title":"Polymer Science: A Comprehensive Reference","first-page":"397","article-title":"Polymerization of Oxazolines","author":"Kobayashi","year":"2012"},{"key":"10.1016\/j.addr.2026.115975_bb0625","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0079-6700(95)00020-8","article-title":"Polymerization of oxazolines","volume":"21","author":"Aoi","year":"1996","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0630","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1021\/ma00038a031","article-title":"Novel multifunctional initiators for polymerization of 2-oxazolines","volume":"25","author":"Kobayashi","year":"1992","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109273","article-title":"End-group functionalization of poly(2-oxazoline)s using methyl bromoacetate as initiator followed by direct amidation","volume":"120","author":"Podevyn","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0640","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/macp.200700506","article-title":"Acetyl halide initiator screening for the cationic ring-opening polymerization of 2-Ethyl-2-Oxazoline","volume":"209","author":"Paulus","year":"2008","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.addr.2026.115975_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2026.114515","article-title":"An azide-containing initiator for the cationic ring-opening-polymerization of 2-oxazolines","volume":"245","author":"Meyer","year":"2026","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0650","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3762\/bjoc.6.96","article-title":"Synthesis and crystal structures of multifunctional tosylates as basis for star-shaped poly(2-ethyl-2-oxazoline)s","volume":"6","author":"Hoogenboom","year":"2010","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0655","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/marc.200800293","article-title":"Kinetic investigations on the polymerization of 2-Oxazolines using Pluritriflate Initators","volume":"29","author":"Luxenhofer","year":"2008","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0660","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/pi.3103","article-title":"Star poly(2-ethyl-2-oxazoline)s\u2014synthesis and thermosensitivity","volume":"60","author":"Kowalczuk","year":"2011","journal-title":"Polym. Int."},{"key":"10.1016\/j.addr.2026.115975_bb0665","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1039\/D4PY01422G","article-title":"Cationic ring-opening polymerization of 2-oxazolines in \u03b3-butyrolactones using various initiators","volume":"16","author":"Chen","year":"2025","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0670","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1163\/156855509X412090","article-title":"Preparation of methacrylate end-functionalized poly(2-ethyl-2-oxazoline) macromonomers","volume":"12","author":"Weber","year":"2009","journal-title":"Des. Monomers Polym."},{"key":"10.1016\/j.addr.2026.115975_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109281","article-title":"Telechelic poly(2-oxazoline)s","volume":"121","author":"Delaittre","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0680","doi-asserted-by":"crossref","first-page":"10620","DOI":"10.1039\/c1cc14075b","article-title":"One-pot synthesis of cyclopentadienyl endcapped poly(2-ethyl-2-oxazoline) and subsequent ambient temperature Diels\u2013Alder conjugations","volume":"47","author":"Glassner","year":"2011","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0685","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/macp.201000556","article-title":"Click-chemistry: an alternative way to functionalize poly(2-methyl-2-oxazoline)","volume":"212","author":"Volet","year":"2011","journal-title":"Macromol. Chem. Phys."},{"key":"10.1016\/j.addr.2026.115975_bb0690","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/pi.5457","article-title":"Poly(2-oxazoline)s: a comprehensive overview of polymer structures and their physical properties","volume":"67","author":"Glassner","year":"2018","journal-title":"Polym. Int."},{"key":"10.1016\/j.addr.2026.115975_bb0695","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1002\/pi.6426","article-title":"Poly(2-oxazoline)s: a comprehensive overview of polymer structures and their physical properties\u2014an update","volume":"71","author":"Jana","year":"2022","journal-title":"Polym. Int."},{"key":"10.1016\/j.addr.2026.115975_bb0700","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1021\/bc00030a001","article-title":"New Amphipatic polymer-lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes","volume":"5","author":"Woodle","year":"1994","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0705","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bc200049d","article-title":"Polyoxazoline: chemistry, properties, and applications in drug delivery","volume":"22","author":"Viegas","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13758-011-0001-y","article-title":"Comparative stability studies of poly(2-methyl-2-oxazoline) and poly(ethylene glycol) brush coatings","volume":"7","author":"Pidhatika","year":"2012","journal-title":"Biointerphases"},{"key":"10.1016\/j.addr.2026.115975_bb0715","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.biomaterials.2014.02.029","article-title":"On the biodegradability of polyethylene glycol, polypeptoids and poly(2-oxazoline)s","volume":"35","author":"Ulbricht","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtla.2020.100763","article-title":"Degradation and excretion of poly(2-oxazoline) based hemostatic materials","volume":"12","author":"Boerman","year":"2020","journal-title":"Materialia"},{"key":"10.1016\/j.addr.2026.115975_bb0725","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mabi.201200080","article-title":"Partial hydrolysis of poly(2-ethyl-2-oxazoline) and potential implications for biomedical applications?","volume":"12","author":"Van Kuringen","year":"2012","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.addr.2026.115975_bb0730","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1021\/la702917z","article-title":"Poly-2-methyl-2-oxazoline: a peptide-like polymer for protein-repellent surfaces","volume":"24","author":"Konradi","year":"2008","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115975_bb0735","doi-asserted-by":"crossref","first-page":"9462","DOI":"10.1016\/j.biomaterials.2010.08.033","article-title":"The role of the interplay between polymer architecture and bacterial surface properties on the microbial adhesion to polyoxazoline-based ultrathin films","volume":"31","author":"Pidhatika","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0740","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-020-00369-y","article-title":"Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers","volume":"3","author":"Huckaby","year":"2020","journal-title":"Commun. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0745","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s42004-022-00709-0","article-title":"Structural determination of an antibody that specifically recognizes polyethylene glycol with a terminal methoxy group","volume":"5","author":"Nguyen","year":"2022","journal-title":"Commun. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0750","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/cncr.22739","article-title":"Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients","volume":"110","author":"Armstrong","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.addr.2026.115975_bb0755","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12929-019-0589-7","article-title":"Structural basis of polyethylene glycol recognition by antibody","volume":"27","author":"Lee","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0760","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.eurpolymj.2016.10.041","article-title":"POxylation as an alternative stealth coating for biomedical applications","volume":"88","author":"Bludau","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0765","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-025-57648-2","article-title":"Species differences in opsonization and phagocyte recognition of preclinical poly-2-alkyl-2-oxazoline-coated nanoparticles","volume":"16","author":"Tavano","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0770","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1039\/D5NJ01501D","article-title":"Intelligent stealth andrographolide imprinted drug carrier of poly(2-ethyl-2-oxazoline) with multi-stimuli responsiveness and A549 lung cancer cell cytotoxicity","volume":"49","author":"Qi","year":"2025","journal-title":"New J. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0775","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/bioengineering9080363","article-title":"Naturally equipped urinary exosomes coated poly (2\u2212ethyl\u22122\u2212oxazoline)\u2212poly (D, L\u2212lactide) nanocarriers for the pre\u2212clinical translation of breast cancer","volume":"9","author":"Ni","year":"2022","journal-title":"Bioengineering"},{"key":"10.1016\/j.addr.2026.115975_bb0780","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/mds.28027","article-title":"Once-weekly subcutaneous delivery of polymer-linked Rotigotine (SER-214) provides continuous plasma levels in Parkinson's disease patients","volume":"35","author":"Olanow","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.addr.2026.115975_bb0785","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.actbio.2020.11.047","article-title":"Alternating stealth polymer coatings between administrations minimizes toxic and antibody immune responses towards nanomedicine treatment regimens","volume":"121","author":"Li","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2026.115975_bb0790","first-page":"19890","article-title":"Mitigating the effects of persistent antipolymer immune reactions in nanomedicine: evaluating materials-based approaches using molecular imaging","volume":"18","author":"Humphries","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb0795","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1016\/j.biomaterials.2010.02.057","article-title":"Doubly amphiphilic poly(2-oxazoline)s as high-capacity delivery systems for hydrophobic drugs","volume":"31","author":"Luxenhofer","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0800","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biomaterials.2016.06.002","article-title":"A high capacity polymeric micelle of paclitaxel: implication of high dose drug therapy to safety and in vivo anti-cancer activity","volume":"101","author":"He","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0805","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202304033","article-title":"Substituting poly(ethylene glycol) lipids with poly(2-ethyl-2-oxazoline) lipids improves lipid nanoparticle repeat dosing","volume":"13","author":"Sanchez","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb0810","doi-asserted-by":"crossref","first-page":"7785","DOI":"10.1039\/C4TB01383B","article-title":"Preparation and characterizations of poly(2-methyl-2-oxazoline) based antifouling coating by thermally induced immobilization","volume":"2","author":"Bai","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2026.115975_bb0815","doi-asserted-by":"crossref","first-page":"11667","DOI":"10.1002\/anie.201805620","article-title":"Chemical design of non-ionic polymer brushes as biointerfaces: poly(2-oxazine)s outperform both poly(2-oxazoline)s and PEG","volume":"57","author":"Morgese","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0820","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/anie.201712534","article-title":"Cyclic polymer grafts that lubricate and protect damaged cartilage","volume":"57","author":"Morgese","year":"2018","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0825","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202300168","article-title":"Antifouling properties of poly(2-oxazoline)s and poly(2-oxazine)s: direct comparison of polymer-coated surfaces with the same coating parameters","volume":"44","author":"Svoboda","year":"2023","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb0830","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2016.05.048","article-title":"\u03bcPET imaging of the pharmacokinetic behavior of medium and high molar mass 89Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol)","volume":"235","author":"Wyffels","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0835","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jconrel.2007.02.015","article-title":"Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s","volume":"119","author":"Gaertner","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102345","article-title":"Poly(2-oxazoline) nanoparticle delivery enhances the therapeutic potential of vismodegib for medulloblastoma by improving CNS pharmacokinetics and reducing systemic toxicity","volume":"32","author":"Hwang","year":"2021","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2026.115975_bb0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","article-title":"Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments","volume":"192","author":"Wan","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0850","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jlac.19335050104","article-title":"Uber hochpolymere Verbindungen. 81. Mitteilung. Uber eukolloides Poly\u00e4thylenoxyd","volume":"505","author":"Staudinger","year":"1933","journal-title":"Justus Liebigs Ann. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0855","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1021\/ja01863a066","article-title":"Molecular size distribution in ethylene oxide polymers","volume":"62","author":"Flory","year":"1940","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb0860","doi-asserted-by":"crossref","first-page":"7954","DOI":"10.1021\/ja9019148","article-title":"Synthesis and Noncovalent Protein Conjugation of Linear-Hyperbranched PEG-Poly(glycerol) \u03b1,\u03c9n-Telechelics","volume":"131","author":"Wurm","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb0865","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1039\/c2py00489e","article-title":"Functional PEG-based polymers with reactive groups via anionic ROP of tailor-made epoxides","volume":"3","author":"Mangold","year":"2012","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0870","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1021\/acs.macromol.2c00761","article-title":"Anionic ring-opening polymerization of a functional epoxide monomer with an Oxazoline protecting Group for the Synthesis of Polyethers with carboxylic acid pendants","volume":"55","author":"Park","year":"2022","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0875","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.eurpolymj.2016.11.016","article-title":"The chemistry of poly(2-oxazoline)s","volume":"88","author":"Verbraeken","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb0880","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1021\/ma060952a","article-title":"Microwave-assisted cationic ring-opening polymerization of 2-Oxazolines: a powerful method for the synthesis of amphiphilic triblock copolymers","volume":"39","author":"Hoogenboom","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0885","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1039\/D1PY00944C","article-title":"One-pot synthesis of amphiphilic multiblock poly(2-oxazoline)s via Para-fluoro-thiol click reactions","volume":"12","author":"Zhao","year":"2021","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0890","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.polymer.2014.11.005","article-title":"Molecular weight distribution and endgroup functionality of poly(2-ethyl-2-oxazoline) prepolymers","volume":"56","author":"Celebi","year":"2015","journal-title":"Polymer"},{"key":"10.1016\/j.addr.2026.115975_bb0895","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1021\/ma0474170","article-title":"Investigation of the living cationic ring-opening polymerization of 2-methyl-, 2-ethyl-, 2-Nonyl-, and 2-Phenyl-2-oxazoline in a single-mode microwave reactor","volume":"38","author":"Wiesbrock","year":"2005","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0900","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202404972","article-title":"Facile generation of heterotelechelic poly(2-oxazoline)s towards accelerated exploration of poly(2-oxazoline)-based nanomedicine","volume":"63","author":"Van Guyse","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.addr.2026.115975_bb0905","doi-asserted-by":"crossref","first-page":"14125","DOI":"10.1039\/D0TC02830D","article-title":"F\u00f6rster resonance energy transfer in fluorophore labeled poly(2-ethyl-2-oxazoline)s","volume":"8","author":"Merckx","year":"2020","journal-title":"J. Mater. Chem. C"},{"key":"10.1016\/j.addr.2026.115975_bb0910","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1039\/C9PY00013E","article-title":"Synthesis of defined high molar mass poly(2-methyl-2-oxazoline)","volume":"10","author":"Sedlacek","year":"2019","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0915","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1021\/ar900158p","article-title":"Hyperbranched polyglycerols: from the controlled synthesis of biocompatible polyether polyols to multipurpose applications","volume":"43","author":"Wilms","year":"2010","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2026.115975_bb0920","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1021\/bm5002608","article-title":"Beyond poly(ethylene glycol): linear polyglycerol as a multifunctional polyether for biomedical and pharmaceutical applications","volume":"15","author":"Thomas","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0925","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/pol.1969.160070302","article-title":"Polymerization of cyclic imino ethers. VI. X-ray study of some polyaziridines","volume":"7","author":"Litt","year":"1969","journal-title":"Journal of Polymer Science Part A-2: Polymer Physics"},{"key":"10.1016\/j.addr.2026.115975_bb0930","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/masy.201400023","article-title":"Main-Chain chiral poly(2-oxazoline)s: influence of alkyl side-Chain on secondary structure formation in the solid state","volume":"350","author":"Bloksma","year":"2015","journal-title":"Macromol. Symp."},{"key":"10.1016\/j.addr.2026.115975_bb0935","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/polb.23967","article-title":"Revisiting the crystallization of poly(2-alkyl-2-oxazoline)s","volume":"54","author":"Demirel","year":"2016","journal-title":"Journal of Polymer Science Part B: Polymer Physics"},{"key":"10.1016\/j.addr.2026.115975_bb0940","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.progpolymsci.2011.10.002","article-title":"Temperature responsive bio-compatible polymers based on poly(ethylene oxide) and poly(2-oxazoline)s","volume":"37","author":"Weber","year":"2012","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb0945","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1021\/ma00045a044","article-title":"Double isomerization polymerization of 2-amino-2-oxazolines: a novel ring-opening polymerization accompanying isomerization of growing species","volume":"25","author":"Miyamoto","year":"1992","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0950","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1021\/ma00048a004","article-title":"Ring-opening isomerization polymerization of cyclic iminocarbonates","volume":"25","author":"Miyamoto","year":"1992","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0955","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/pola.26437","article-title":"Chiral and water-soluble poly(2-oxazoline)s","volume":"51","author":"Luxenhofer","year":"2013","journal-title":"J. Polym. Sci. A Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0960","doi-asserted-by":"crossref","first-page":"25753","DOI":"10.1021\/jacs.3c09240","article-title":"Peptide-mimicking poly(2-oxazoline)s possessing potent antifungal activity and BBB penetrating property to treat invasive infections and meningitis","volume":"145","author":"Jiang","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb0965","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1039\/C4PY00434E","article-title":"Zwitterionic poly(2-oxazoline)s as promising candidates for blood contacting applications","volume":"5","author":"Tauhardt","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0970","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1021\/ma052515m","article-title":"Click chemistry with poly(2-oxazoline)s","volume":"39","author":"Luxenhofer","year":"2006","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0975","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2022.08.004","article-title":"Poly(2-oxazoline) \u2013 Ferrostatin-1 drug conjugates inhibit ferroptotic cell death","volume":"350","author":"Morrow","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb0980","doi-asserted-by":"crossref","first-page":"4618","DOI":"10.1021\/acs.biomac.1c00923","article-title":"Nitrile-functionalized poly(2-oxazoline)s as a versatile platform for the development of polymer therapeutics","volume":"22","author":"Mazrad","year":"2021","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.09.003","article-title":"Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: in vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues","volume":"146","author":"Sedlacek","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb0990","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1039\/D0PY00602E","article-title":"Drug\u2013polymer conjugates with dynamic cloud point temperatures based on poly(2-oxazoline) copolymers","volume":"11","author":"Park","year":"2020","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109217","article-title":"Influence of side-chain length on long-term release kinetics from poly(2-oxazoline)-drug conjugate networks","volume":"120","author":"Park","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1000","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1021\/bm501697t","article-title":"Side-chain cysteine-functionalized poly(2-oxazoline)s for multiple peptide conjugation by native chemical ligation","volume":"16","author":"Schmitz","year":"2015","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1005","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1039\/C9PY00943D","article-title":"Poly(2-amino-2-oxazoline)s: a new class of thermoresponsive polymers","volume":"10","author":"Sedlacek","year":"2019","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1010","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/acs.energyfuels.3c05107","article-title":"Kinetic hydrate inhibition from Thermoresponsive poly(2-amino-2-oxazoline)s: size and shape of the hydrophobic groups are critical for performance","volume":"38","author":"Kelland","year":"2024","journal-title":"Energy Fuels"},{"key":"10.1016\/j.addr.2026.115975_bb1015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/marc.201100587","article-title":"Thermoresponsive poly(2-oxazine)s","volume":"33","author":"Bloksma","year":"2012","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110299","article-title":"Poly(2-oxazine)s: a comprehensive overview of the polymer structures, physical properties and applications","volume":"147","author":"Varanaraja","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1025","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1039\/D4PY00332B","article-title":"Comparison of the hydrophilicity of water-soluble poly(2-alkyl-2-oxazoline)s, poly(2-alkyl-2-oxazine)s and poly(2,4-dialkyl-2-oxazoline)s","volume":"15","author":"Mint","year":"2024","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1030","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1021\/acs.macromol.7b02665","article-title":"POx as an alternative to PEG? A hydrodynamic and light scattering study","volume":"51","author":"Grube","year":"2018","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0168-3659(89)90013-8","article-title":"Soluble polymeric carriers for drug delivery. Part 2. Preparation and in vivo behaviour of N-acylethylenimine copolymers","volume":"10","author":"Goddard","year":"1989","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1040","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/pola.26564","article-title":"In vitro hemocompatibility and cytotoxicity study of poly(2-methyl-2-oxazoline) for biomedical applications","volume":"51","author":"Bauer","year":"2013","journal-title":"J. Polym. Sci. A Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1045","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s10856-011-4346-z","article-title":"In vitro bio-immunological and cytotoxicity studies of poly(2-oxazolines)","volume":"22","author":"Kronek","year":"2011","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.addr.2026.115975_bb1050","doi-asserted-by":"crossref","DOI":"10.1088\/1742-6596\/1282\/1\/012069","article-title":"Hemocompatibility study of surface-attached antibiofouling polymer monolayers","volume":"1282","author":"Pidhatika","year":"2019","journal-title":"J. Phys. Conf. Ser."},{"key":"10.1016\/j.addr.2026.115975_bb1055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/acs.biomac.6b01392","article-title":"The label matters: \u03bcPET imaging of the biodistribution of low molar mass 89Zr and 18F-labeled poly(2-ethyl-2-oxazoline)","volume":"18","author":"Glassner","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1060","article-title":"A recent state of art on polyoxazoline-containing antifouling coatings for biological and environmental applications","volume":"186","author":"Arsenie","year":"2024","journal-title":"Prog. Org. Coat."},{"key":"10.1016\/j.addr.2026.115975_bb1065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.eurpolymj.2016.11.003","article-title":"Polyoxazoline biointerfaces by surface grafting","volume":"88","author":"Morgese","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1070","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1021\/acs.biomac.9b00006","article-title":"Protein Adsorption and Coordination-Based End-Tethering of Functional Polymers on Metal\u2013Phenolic Network Films","volume":"20","author":"Tardy","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1075","doi-asserted-by":"crossref","first-page":"8303","DOI":"10.1021\/ja000774f","article-title":"Surveying for surfaces that resist the adsorption of proteins","volume":"122","author":"Chapman","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb1080","doi-asserted-by":"crossref","first-page":"5605","DOI":"10.1021\/la010384m","article-title":"A survey of structure\u2212property relationships of surfaces that resist the adsorption of protein","volume":"17","author":"Ostuni","year":"2001","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115975_bb1085","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/la900083s","article-title":"Interaction of blood plasma with antifouling surfaces","volume":"25","author":"Rodriguez Emmenegger","year":"2009","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115975_bb1090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2026.114612","article-title":"The role of hydrophilic linkers in next-generation antibody-drug conjugates","volume":"391","author":"Fu","year":"2026","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1095","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1002\/adfm.201203470","article-title":"Nonfouling response of hydrophilic uncharged polymers","volume":"23","author":"Serrano","year":"2013","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb1100","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1021\/acs.biomac.9b00751","article-title":"Poly(2-oxazoline)s one-pot polymerization and surface coating: from synthesis to antifouling properties out-performing poly(ethylene oxide)","volume":"20","author":"Svoboda","year":"2019","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1105","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1039\/C7PY02137B","article-title":"Design and characterization of ultrastable, biopassive and lubricious cyclic poly(2-alkyl-2-oxazoline) brushes","volume":"9","author":"Yan","year":"2018","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1110","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/acsmacrolett.8b00847","article-title":"Surface density variation within cyclic polymer brushes reveals topology effects on their Nanotribological and biopassive properties","volume":"7","author":"Divandari","year":"2018","journal-title":"ACS Macro Lett."},{"key":"10.1016\/j.addr.2026.115975_bb1115","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202424873","article-title":"Poly(2-hydroxymethyl-2-oxazoline) as super-hydrophilic antifouling polymer","volume":"64","author":"Jana","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.addr.2026.115975_bb1120","article-title":"Current status, challenges and prospects of antifouling materials for oncology applications","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.addr.2026.115975_bb1125","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1021\/la304886r","article-title":"Complete identification of proteins responsible for human blood plasma fouling on poly(ethylene glycol)-based surfaces","volume":"29","author":"Riedel","year":"2013","journal-title":"Langmuir"},{"key":"10.1016\/j.addr.2026.115975_bb1130","doi-asserted-by":"crossref","first-page":"21538","DOI":"10.1021\/jacs.5c02716","article-title":"Isomerization of poly(ethylene glycol): a strategy for the evasion of anti-PEG antibody recognition","volume":"147","author":"Dreier","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb1135","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202521061","article-title":"Overcoming PEG antigenicity: statistical PEG isomers reduce antibody binding","volume":"13","author":"Deuker","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2026.115943","article-title":"From PEG to randomized PEG: a macromolecular strategy tackling PEG immunogenicity","volume":"238","author":"Schmidt","year":"2026","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2026.115975_bb1145","article-title":"Positron emission tomography reveals the impact of polymer structure of PEG alternatives on accelerated blood clearance of liposomes","author":"Centanni","year":"2026","journal-title":"ChemRxiv"},{"key":"10.1016\/j.addr.2026.115975_bb1150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2007.11.005","article-title":"Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes","volume":"354","author":"Ishida","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb1155","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/wnan.1339","article-title":"Anti-PEG immunity: emergence, characteristics, and unaddressed questions","volume":"7","author":"Yang","year":"2015","journal-title":"WIREs Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.addr.2026.115975_bb1160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acsbiomedchemau.4c00042","article-title":"Antigenicity extension: a novel concept explained by the immunogenicity of PEG","volume":"5","author":"Shiraishi","year":"2025","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.addr.2026.115975_bb1165","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s11095-012-0934-y","article-title":"Accelerated blood clearance of PEGylated PLGA nanoparticles following repeated injections: effects of polymer dose, PEG coating, and encapsulated anticancer drug","volume":"30","author":"Saadati","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115975_bb1170","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2007.02.010","article-title":"Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes","volume":"119","author":"Wang","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1175","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2010.08.012","article-title":"Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems","volume":"147","author":"Mohanan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jconrel.2023.06.027","article-title":"Anti-PEG IgM production induced by PEGylated liposomes as a function of administration route","volume":"360","author":"Takata","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1185","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jconrel.2022.12.005","article-title":"The mechanisms of anti-PEG immune response are different in the spleen and the lymph nodes","volume":"353","author":"Grenier","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1190","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s11095-011-0523-5","article-title":"Immunogenicity of therapeutic proteins: the use of animal models","volume":"28","author":"Brinks","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2026.115975_bb1195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.09.047","article-title":"Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin","volume":"476","author":"Suzuki","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb1200","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40005-018-0406-4","article-title":"Physicochemical properties of particulate vaccine adjuvants: their pivotal role in modulating immune responses","volume":"49","author":"Bastola","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.addr.2026.115975_bb1205","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jconrel.2005.04.003","article-title":"Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes","volume":"105","author":"Ishida","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1210","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.7150\/thno.22164","article-title":"Pre-existing anti-polyethylene glycol antibody reduces the therapeutic efficacy and pharmacokinetics of PEGylated liposomes","volume":"8","author":"Hsieh","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2026.115975_bb1215","doi-asserted-by":"crossref","first-page":"R12","DOI":"10.1186\/ar1861","article-title":"Control of hyperuricemia in subjects with refractory gout, and induction of antibody against poly(ethylene glycol) (PEG), in a phase I trial of subcutaneous PEGylated urate oxidase","volume":"8","author":"Ganson","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.addr.2026.115975_bb1220","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/acssensors.4c03184","article-title":"Multiplexing label-free polymeric Nanocarriers via Antipolymer antibodies","volume":"10","author":"Humphries","year":"2025","journal-title":"ACS Sens."},{"key":"10.1016\/j.addr.2026.115975_bb1225","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1021\/acsnano.8b01806","article-title":"C1q-mediated complement activation and C3 Opsonization trigger recognition of stealth poly(2-methyl-2-oxazoline)-coated silica nanoparticles by human phagocytes","volume":"12","author":"Tavano","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb1230","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1021\/acs.bioconjchem.7b00630","article-title":"18F-Radiolabeling and in vivo analysis of SiFA-derivatized polymeric core\u2013shell nanoparticles","volume":"29","author":"Berke","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1235","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.nano.2017.03.002","article-title":"Effect of particle size on the biodistribution, toxicity, and efficacy of drug-loaded polymeric nanoparticles in chemoradiotherapy","volume":"13","author":"Caster","year":"2017","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2026.115975_bb1240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/sj.bjc.6602479","article-title":"NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel","volume":"92","author":"Hamaguchi","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2026.115975_bb1245","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-3659(01)00275-9","article-title":"In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy","volume":"72","author":"Kim","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1250","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nnano.2011.166","article-title":"Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size","volume":"6","author":"Cabral","year":"2011","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2026.115975_bb1255","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1021\/acsnano.7b07878","article-title":"Drug combination synergy in Worm-like polymeric micelles improves treatment outcome for small cell and non-small cell lung Cancer","volume":"12","author":"Wan","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb1260","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1021\/nn406388t","article-title":"Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s","volume":"8","author":"Schulz","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2026.115975_bb1265","doi-asserted-by":"crossref","first-page":"eaba5542","DOI":"10.1126\/sciadv.aba5542","article-title":"High-capacity poly(2-oxazoline) formulation of TLR 7\/8 agonist extends survival in a chemo-insensitive, metastatic model of lung adenocarcinoma","volume":"6","author":"Vinod","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.addr.2026.115975_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121140","article-title":"Bioequivalence assessment of high-capacity polymeric micelle nanoformulation of paclitaxel and Abraxane\u00ae in rodent and non-human primate models using a stable isotope tracer assay","volume":"278","author":"Hwang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101884","article-title":"High-dose paclitaxel and its combination with CSF1R inhibitor in polymeric micelles for chemoimmunotherapy of triple negative breast cancer","volume":"51","author":"Lim","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.addr.2026.115975_bb1280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.02.024","article-title":"Poly(2-oxazoline) based micelles with high capacity for 3rd generation taxoids: preparation, in vitro and in vivo evaluation","volume":"208","author":"He","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1285","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2147\/IJN.S298093","article-title":"Anti-cancer activity based on the high docetaxel loaded poly(2-oxazoline)s micelles","volume":"16","author":"Xu","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.addr.2026.115975_bb1290","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.nano.2015.02.004","article-title":"Delivering nanomedicines to patients: a practical guide","volume":"11","author":"Eaton","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2026.115975_bb1295","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2026.115975_bb1300","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/j.vaccine.2023.05.029","article-title":"Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccination","volume":"41","author":"Zhou","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2026.115975_bb1305","doi-asserted-by":"crossref","first-page":"4591","DOI":"10.1021\/acs.biomac.4c00651","article-title":"Tailored Monoacyl poly(2-oxazoline)- and poly(2-oxazine)-lipids as PEG-lipid alternatives for stabilization and delivery of mRNA-lipid nanoparticles","volume":"25","author":"He","year":"2024","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1310","article-title":"PEG-free tunable poly(2-oxazoline) lipids modulate LNP biodistribution and expression in vivo after intramuscular administration","author":"Basham","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.addr.2026.115975_bb1315","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/acs.biomac.4c01587","article-title":"Cyclic poly(2-methyl-2-oxazoline)-lipid conjugates are good alternatives to poly(ethylene glycol)-lipids for lipid nanoparticle mRNA formulation","volume":"26","author":"Golba","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1320","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.eurpolymj.2016.09.052","article-title":"Clinical development of a poly(2-oxazoline) (POZ) polymer therapeutic for the treatment of Parkinson's disease \u2013 proof of concept of POZ as a versatile polymer platform for drug development in multiple therapeutic indications","volume":"88","author":"Moreadith","year":"2017","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1325","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2025.114392","article-title":"Overcoming the PEG dilemma with poly(2-ethyl-2-oxazoline) lipids in lipid nanoparticle formulations","volume":"241","author":"Moreadith","year":"2025","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1330","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.3390\/vaccines11061020","article-title":"Anaphylatoxin complement 5a in Pfizer BNT162b2-induced immediate-type vaccine hypersensitivity reactions","volume":"11","author":"Lim","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.addr.2026.115975_bb1335","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/13506129.2024.2388713","article-title":"Anti-PEG antibodies associated with reduced therapeutic effect of patisiran in patients with hereditary transthyretin amyloidosis","volume":"31","author":"Pilebro","year":"2024","journal-title":"Amyloid"},{"key":"10.1016\/j.addr.2026.115975_bb1340","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.biomaterials.2013.09.016","article-title":"Comparative efficacy of blood cell immunocamouflage by membrane grafting of methoxypoly(ethylene glycol) and polyethyloxazoline","volume":"35","author":"Kyluik-Price","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb1345","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201601115","article-title":"Radiolabelled polymeric materials for imaging and treatment of cancer: quo vadis?","volume":"6","author":"Pant","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb1350","doi-asserted-by":"crossref","DOI":"10.1038\/srep33798","article-title":"Polyoxazoline multivalently conjugated with indocyanine green for sensitive in vivo photoacoustic imaging of tumors","volume":"6","author":"Kanazaki","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2026.115975_bb1355","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jconrel.2016.02.017","article-title":"Feasibility of poly(ethylene glycol) derivatives as diagnostic drug carriers for tumor imaging","volume":"226","author":"Kanazaki","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2026.115975_bb1360","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2019.109241","article-title":"Tuning drug release from polyoxazoline-drug conjugates","volume":"120","author":"Harris","year":"2019","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2021.110447","article-title":"Poly(2-ethyl-2-oxazoline) bottlebrushes: how nanomaterial dimensions can influence biological interactions","volume":"151","author":"Pizzi","year":"2021","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1370","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1021\/bc5004718","article-title":"Poly(2-ethyl-2-oxazoline)\u2013doxorubicin conjugate-based dual endosomal pH-sensitive micelles with enhanced antitumor efficacy","volume":"26","author":"Li","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1375","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1021\/acs.biomac.0c00659","article-title":"Poly(2-ethyl-2-oxazoline) conjugates with salicylic acid via degradable modular Ester linkages","volume":"21","author":"Bernhard","year":"2020","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1380","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/mds.25625","article-title":"Rotigotine polyoxazoline conjugate SER-214 provides robust and sustained antiparkinsonian benefit","volume":"28","author":"Eskow Jaunarajs","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.addr.2026.115975_bb1385","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202411354","article-title":"Poly(2-ethyl-2-oxazoline) (POx) as poly(ethylene glycol) (PEG)-lipid substitute for lipid nanoparticle formulations","volume":"21","author":"Holick","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.addr.2026.115975_bb1390","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1021\/acs.analchem.5c07351","article-title":"POx-lipids as an alternative to PEG-lipids? Multimethod assessment of chemistry and structure","volume":"98","author":"Tsarenko","year":"2026","journal-title":"Anal. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1395","doi-asserted-by":"crossref","first-page":"13628","DOI":"10.1021\/acsanm.5c00636","article-title":"Poly(sarcosine) and poly(2-ethyl-2-oxazoline) tethered to mRNA provide stealth properties to mRNA Polyplexes","volume":"8","author":"Marx","year":"2025","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.addr.2026.115975_bb1400","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1021\/ma60042a054","article-title":"A new route to optically active linear poly(propylenimine)","volume":"7","author":"Saegusa","year":"1974","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1405","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1039\/b921467d","article-title":"Secondary structure formation of main-chain chiral poly(2-oxazoline)s in solution","volume":"6","author":"Bloksma","year":"2010","journal-title":"Soft Matter"},{"key":"10.1016\/j.addr.2026.115975_bb1410","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1021\/acs.macromol.2c00229","article-title":"Synthesis and investigation of chiral poly(2,4-disubstituted-2-oxazoline)-based triblock copolymers, their self-assembly, and formulation with chiral and achiral drugs","volume":"55","author":"Yang","year":"2022","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1415","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1021\/acs.biomac.2c01105","article-title":"Probing the biocompatibility and immune cell Association of Chiral, water-soluble, bottlebrush poly(2-oxazoline)s","volume":"24","author":"Pizzi","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1420","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.112964","article-title":"Influence of chirality on protein corona formation of low-fouling chiral poly(2-oxazoline) coated nanoparticles","volume":"210","author":"Pizzi","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.addr.2026.115975_bb1425","doi-asserted-by":"crossref","first-page":"17905","DOI":"10.1039\/D6SC05017D","article-title":"Antibody-mediated recognition of chiral poly(2-oxazoline) nanorods driven by enantioselectivity","volume":"17","author":"Pizzi","year":"2026","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb1430","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1039\/D1SC00938A","article-title":"Stealth nanorods via the aqueous living crystallisation-driven self-assembly of poly(2-oxazoline)s","volume":"12","author":"Finnegan","year":"2021","journal-title":"Chem. Sci."},{"key":"10.1016\/j.addr.2026.115975_bb1435","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/marc.201100138","article-title":"Poly(cyclic imino ether)s beyond 2-Substituted-2-oxazolines","volume":"32","author":"Bloksma","year":"2011","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb1440","article-title":"Cytotoxicity of 2-oxazines and poly(2-oxazine)s in mouse fibroblast","author":"Kronekov\u00e1","year":"2018","journal-title":"ChemRxiv"},{"key":"10.1016\/j.addr.2026.115975_bb1445","doi-asserted-by":"crossref","first-page":"10667","DOI":"10.1021\/acs.macromol.1c01794","article-title":"Self-assembly, drug encapsulation, and cellular uptake of block and gradient copolymers of 2-Methyl-2-oxazine and 2-n-propyl\/butyl-2-oxazoline","volume":"54","author":"Babuka","year":"2021","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1450","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1039\/D3PY00399J","article-title":"Length-tuneable biocompatible block copolymer nanorods with a poly(2-methyl-2-oxazine)-corona via heat-induced crystallisation-driven self-assembly","volume":"14","author":"Warne","year":"2023","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1455","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1021\/jacs.9b02607","article-title":"Unexpected reactivity switch in the statistical copolymerization of 2-Oxazolines and 2-Oxazines enabling the one-step synthesis of amphiphilic gradient copolymers","volume":"141","author":"Sedlacek","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb1460","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1021\/jacs.7b05376","article-title":"Drug specificity, synergy and antagonism in ultrahigh capacity poly(2-oxazoline)\/poly(2-oxazine) based formulations","volume":"139","author":"Lubtow","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2026.115975_bb1465","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202402029","article-title":"Impact of drug conjugation site and corona chemistry on the therapeutic activity of polymer nanorod \u2013 drug conjugates","volume":"13","author":"Warne","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.addr.2026.115975_bb1470","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1021\/acs.biomac.4c01340","article-title":"The topology of poly(2-methyl-2-oxazine) shells on nanoparticles determines their interaction with serum and uptake by immune cells","volume":"26","author":"Morbidelli","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1475","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19947-8","article-title":"Enhanced dispersion stability of gold nanoparticles by the physisorption of cyclic poly(ethylene glycol)","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115975_bb1480","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1039\/C8PY00299A","article-title":"Promotion of micelle stability via a cyclic hydrophilic moiety","volume":"9","author":"Wang","year":"2018","journal-title":"Polym. Chem."},{"key":"10.1016\/j.addr.2026.115975_bb1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120843","article-title":"Interactions of core cross-linked poly(2-oxazoline) and poly(2-oxazine) micelles with immune cells in human blood","volume":"274","author":"Leiske","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2026.115975_bb1490","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202500781","article-title":"A non-antigenic randomized polyethylene glycol\/poly(2-phenyl-2-oxazine)-based drug delivery platform","volume":"47","author":"Schmidt","year":"2026","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.addr.2026.115975_bb1495","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1021\/acs.macromol.2c02050","article-title":"Poly(2-oxazoline) with pendant hydroxyl groups via a silyl ether-based protecting group","volume":"55","author":"Kim","year":"2022","journal-title":"Macromolecules"},{"key":"10.1016\/j.addr.2026.115975_bb1500","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1021\/mp300159u","article-title":"Synergistic combinations of multiple chemotherapeutic agents in high capacity poly(2-oxazoline) micelles","volume":"9","author":"Han","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2026.115975_bb1505","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2022.111521","article-title":"The future of poly(2-oxazoline)s","volume":"179","author":"Hoogenboom","year":"2022","journal-title":"Eur. Polym. J."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26002097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:52:49Z","timestamp":1791564769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26002097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":301,"alternative-id":["S0169409X26002097"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115975","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Poly(2-oxazoline)s and poly(2-oxazine)s: An overview of stealth properties, pharmacokinetics, and immunogenicity","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115975","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115975"}}